Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS)

Julie Scott, DNP
Julie Scott, DNP
Laugier-Hunziker Syndrome |cancerGO

What is Laugier-Hunziker Syndrome (LHS)

Laugier-Hunziker Syndrome (LHS) is a rare disorder that affects the pigment of the skin and mucous membranes of the mouth. LHS is also known as idiopathic lenticular mucocutaneous pigmentation.

LHS is a benign (non-cancerous) condition and does not cause any serious health problems. The main symptom of LHS is the appearance of dark pigmentation on the lips, inside of the mouth, and sometimes on the fingers and toes. The pigmentation is typically brown or black and appears as small, flat spots or patches.

Causes:

The exact cause of LHS is unknown, but it is thought to be a combination of genetic and environmental factors. Some cases of LHS have been associated with mutations in the TERT gene, which is involved in the process of cell division and aging. Other cases have been linked to exposure to certain medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal therapies.

Diagnosis:

LHS is usually diagnosed based on the pigmentation pattern which is characteristic of the disorder, as well as a thorough medical history. In some cases, a skin biopsy may be performed to rule out other conditions that may cause similar symptoms.

Treatment:

Treatment for LHS is usually not necessary as the condition does not cause any health problems. However, if the pigmentation is causing cosmetic concerns, treatment options such as laser therapy, cryotherapy, and topical creams may be considered.

It is important to note that LHS does not increase the risk of developing skin cancer or other health problems. However, it is still important to practice good sun protection habits, such as wearing protective clothing and sunscreen, to prevent damage to the skin

 

Julie Scott, DNP
Julie Scott, DNP
Julie is an oncology certified Oncology Nurse Practitioner with over a decade of medical oncology experience. In addition to her clinical work, she is an accomplished healthcare writer providing oncology content for various publications. She also serves as an adjunct faculty member for a Master's nursing program and a chair for Doctoral nursing students.

Download our
mobile app

Share this post
You may also like
Articles
The Benefit of Routine Bladder Cancer Screenings
November 21, 2022

What is Bladder Cancer? Bladder cancer is a disease in which abnormal cells begin to grow in the cells that line the bladder. Screening tests are done to look for cancer when there are no signs or symptoms. Currently, there is no screening test available for bladder cancer. However, the…

Julie Scott, DNP

author

Articles
Multiple Endocrine Neoplasia (MEN): Types, Symptoms, Treatments & More
January 23, 2023

What is Multiple endocrine neoplasia (MEN) Multiple endocrine neoplasia (MEN) Is a group of inherited disorders that affect the endocrine glands, which are the glands that produce hormones. There are several types of MEN, but the most common are MEN type 1 and MEN type 2. MEN type 1 is…

Julie Scott, DNP

author

Articles
Colorectal cancer treatment (CRC)
November 8, 2022

Treatment is often classified into local therapy or systemic therapy. Local therapy means that it only treats the colon or rectum, and not any other parts of the body. Systemic therapy is treatment that goes around your entire body, treating cancer cells that may be present outside of the colon.…

Julie Scott, DNP

author

cancerGO gives you access to a community

Where are people to listen, answer questions, share information, and offer valuable and timely advice